Get started
Author

Shahram Rahimian

Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2020 · Ani S. Balmanoukian, Jeffrey R. Infante, et al. · Clinical Cancer Research · 57
PDF
Survival of Block and Fascial-Wrapped Diced Cartilage Grafts
2011 · Mohammad Javad Fatemi, Mohammad Esmaeel Hasani, et al. · Annals of Plastic Surgery · 35
Randomized Trial of Physician Alerts for Thromboprophylaxis after Discharge
2013 · Gregory Piazza, Frederick A. Anderson, et al. · The American Journal of Medicine · 29
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301)
2025 · Adi Diab, Paolo A. Ascierto, et al. · Journal of Clinical Oncology · 17
PDF
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301)
2025 · Adi Diab, Paolo A. Ascierto, et al. · Journal of Clinical Oncology · 1
PDF
Supplementary Figure 2 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
Supplementary Table 1 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
Supplementary Figure 4 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
PDF
Supplementary Figure 1 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
PDF
Supplementary Figure 3 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
PDF
Supplementary Figure 2 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
PDF
Supplementary Figure 3 from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
Data from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
Data from Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
2023 · Ani S. Balmanoukian, Jeffrey R. Infante, et al.
Abstract 8642: A Randomized Controlled Trial of Physician Alerts to Prevent Symptomatic Venous Thromboembolism after Hospital Discharge
2011 · Gregory Piazza, Frederick A Anderson, et al. · Circulation
A Comparison Between Diagnostic Methods of Ischemia in Prediction of Digital Gangrene Probability in Hazrate Fateme Hospital
2009 · Seyed Foroutan Seyed Kamal, Shahram Rahimian, et al. · Bushehr University of Medical Sciences Repository (Bushehr University of Medical Sciences)
PDF
Works count: 16
Citation count: 139
H-index: 4
I10-index: 4
Year
Topic
Type